References
- Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923. doi:10.2165/00003088-200443130-00004
- Dunn KE, Bergeria CL, Huhn AS, Strain EC. A systematic review of laboratory evidence for the abuse potential of tramadol in humans. Front Psychiatry. 2019;10:704. doi:10.3389/fpsyt.2019.00704
- World Health Organization (WHO). Expert committee on Drug Dependence. Tramadol Update Review Report. 2014. Available from: https://www.who.int/medicines/areas/quality_safety/6_1_Update.pdf. Accessed April 13, 2019.
- US Food and Drug Administration (FDA). Assessment of abuse potential of drugs. 2017. Available from: https://www.fda.gov/media/116739/download. Accessed May 11, 2019.
- World Health Organization 2017. Grünenthal GmBH Application for inclusion of tramadol into the WHO Model List of Essential medicines (EML). 2017. Available from: https://www.who.int/selection_medicines/committees/expert/21/applications/Grunethal_tramadol.pdf. Accessed April 13, 2019.
- Lu L, Ryan M, Harnett M, Atiee GJ, Reines SA. Comparing the pharmacokinetics of 2 novel intravenous tramadol dosing regimens to oral tramadol: a randomized 3-arm crossover study. Clin Pharmacol Drug Dev. 2019.
- Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ committee on regional anesthesia, executive committee, and administrative council. J Pain. 2016;17(2):131–157.
- Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naïve patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790. doi:10.1136/bmj.j5790
- Minkowitz H, Salazar H, Leiman D, et al. Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial. Drugs R D. 2020. doi:10.1007/s40268-020-00309-0